Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 20, Issue 39, 2014, Pages 14205-14218

  Paradies, Giuseppe ^a   Paradies, Valeria ^a   Ruggiero, Francesca M ^a   Petrosillo, Giuseppe ^b  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

Antioxidants; Cardiolipin; Mitochondrial bioenergetics; Nonalcoholic fatty liver disease; Oxidative stress

Indexed keywords

ANTIOXIDANT; CARDIOLIPIN; CYTOCHROME C; REACTIVE OXYGEN METABOLITE; MITOCHONDRIAL DNA; MULTIENZYME COMPLEX;

APOPTOSIS; BIOENERGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION; OXIDATIVE STRESS; RESPIRATORY CHAIN; REVIEW; ANIMAL; DNA DAMAGE; DRUG EFFECTS; LIPID PEROXIDATION; LIVER; LIVER MITOCHONDRION; METABOLISM; MITOCHONDRIAL DISEASES; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOLIPINS; DNA DAMAGE; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; HUMANS; LIPID PEROXIDATION; LIVER; MITOCHONDRIA, LIVER; MITOCHONDRIAL DISEASES; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES;

EID: 84910147372     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i39.14205     Document Type: Review

References (143)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231 [PMID: 11961152 DOI: 10.1056/NEJMra011775]
2. Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005; 17: 636-641 [PMID: 16160540 DOI: 10.1097/01.mop.0000172816.79637.c5]
3. Ludwig J, McGill DB, Lindor KD. Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997; 12: 398-403 [PMID: 9195388]
4. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343: 1467-1476 [PMID: 11078773 DOI: 10.1056/NEJM200011163432007]
5. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419 [PMID: 10348825 DOI: 10.1016/s0016-5085(99)70506-8]
6. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21: 17-26 [PMID: 11296693 DOI: 10.1055/s-2001-12926]
7. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-1657 [PMID: 12016429 DOI: 10.1053/gast.2002.33573]
8. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845 [PMID: 9547102 DOI: 10.1016/s0016-5085(98)70599-2]
9. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 2008; 44: 1259-1272 [PMID: 18242193]
10. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012; 52: 59-69 [PMID: 22064361 DOI: 10.1016/j.freeradbiomed.2011.10.003]
11. Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013; 58: 1497-1507 [PMID: 23299992 DOI: 10.1002/hep.26226]
12. García-Ruiz C, Baulies A, Mari M, García-Rovés PM, Fernandez-Checa JC. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res 2013; 47: 854-868 [PMID: 23915028 DOI: 10.3109/10715762.2013.830717]
13. Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008; 14: 193-199 [PMID: 18186554 DOI: 10.3748/wjg.14.193]
14. Malassagne B, Ferret PJ, Hammoud R, Tulliez M, Bedda S, Trébéden H, Jaffray P, Calmus Y, Weill B, Batteux F. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology 2001; 121: 1451-1459 [PMID: 11729124 DOI: 10.1053/gast.2001.29590]
15. Alkhouri N, Carter-Kent C, Feldstein AE. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev Gastroenterol Hepatol 2011; 5: 201-212 [PMID: 21476915 DOI: 10.1586/egh.11.6]
16. Syn WK, Choi SS, Diehl AM. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis 2009; 13: 565-580 [PMID: 19818305 DOI: 10.1016/j.cld.2009.07.003]
17. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27-41 [PMID: 11296694 DOI: 10.1055/s-2001-12927]
18. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28 [PMID: 16406828 DOI: 10.1016/j.mito.2005.10.004]
19. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 2005; 42: 928-940 [PMID: 15885365 DOI: 10.1016/j.jhep.2005.03.004]
20. Hensley K, Kotake Y, Sang H, Pye QN, Wallis GL, Kolker LM, Tabatabaie T, Stewart CA, Konishi Y, Nakae D, Floyd RA. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 2000; 21: 983-989 [PMID: 10783322 DOI: 10.1093/carcin/21.5.983]
21. Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, Laudanna AA. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med 2002; 6: 399-406 [PMID: 12417056]
22. Petrosillo G, Portincasa P, Grattagliano I, Casanova G, Matera M, Ruggiero FM, Ferri D, Paradies G. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta 2007; 1767: 1260-1267 [PMID: 17900521 DOI: 10.1016/j.bbabio.2007.07.011]
23. Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999-1007 [PMID: 14512887 DOI: 10.1002/hep.1840380426]
24. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 430-434 [PMID: 10488700 DOI: 10.1016/s0168-8278(99)80033-6]
25. Le TH, Caldwell SH, Redick JA, Sheppard BL, Davis CA, Arseneau KO, Iezzoni JC, Hespenheide EE, Al-Osaimi A, Peterson TC. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2004; 39: 1423-1429 [PMID: 15122772 DOI: 10.1002/hep.20202]
26. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999; 282: 1659-1664 [PMID: 10553793 DOI: 10.1001/jama.282.17.1659]
27. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1992; 1113: 71-133 [PMID: 1550861 DOI: 10.1016/0304-4157(92)90035-9]
28. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000; 39: 257-288 [PMID: 10799718 DOI: 10.1016/s0163-7827(00)00005-9]
29. Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 2008; 65: 2493-2506 [PMID: 18425414 DOI: 10.1007/s00018-008-8030-5]
30. Paradies G, Paradies V, De Benedictis V, Ruggiero FM, Petrosillo G. Functional role of cardiolipin in mitochondrial bioenergetics. Biochim Biophys Acta 2014; 1837: 408-417 [PMID: 24183692 DOI: 10.1016/j.bbabio.2013.10.006]
31. Klingenberg M . Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 2009; 1788: 2048-2058 [PMID: 19539604 DOI: 10.1016/j.bbamem.2009.06.007]
32. Kagan VE, Bayir HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, Jiang J, Stoyanovsky DA, Wipf P, Kochanek PM, Greenberger JS, Pitt B, Shvedova AA, Borisenko G. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med 2009; 46: 1439-1453 [PMID: 19285551 DOI: 10.1016/j.freeradbiomed.2009.03.004]
33. Ott M, Zhivotovsky B, Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 2007; 14: 1243-1247 [PMID: 17431425 DOI: 10.1038/sj.cdd.4402135]
34. Gonzalvez F, Gottlieb E. Cardiolipin: setting the beat of apoptosis. Apoptosis 2007; 12: 877-885 [PMID: 17294083 DOI: 10.1007/s10495-007-0718-8]
35. Petrosillo G, Ruggiero FM, Pistolese M, Paradies G. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis. FEBS Lett 2001; 509: 435-438 [PMID: 11749969 DOI: 10.1016/s0014-5793(01)03206-9]
36. Osman C, Voelker DR, Langer T. Making heads or tails of phospholipids in mitochondria. J Cell Biol 2011; 192: 7-16 [PMID: 21220505 DOI: 10.1083/jcb.201006159]
37. Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Cardiolipin and mitochondrial function in health and disease. Antioxid Redox Signal 2014; 20: 1925-1953 [PMID: 24094094 DOI: 10.1089/ars.2013.5280]
38. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 2007; 292: C33-C44 [PMID: 16899548 DOI: 10.1152/ajpcell.00243.2006]
39. Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging. Free Radic Biol Med 2010; 48: 1286-1295 [PMID: 20176101 DOI: 10.1016/j.freeradbiomed.2010.02.020]
40. Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, Sun C, Liu X, Jefferson LS, Xiong J, Lanoue KF, Chang Z, Lynch CJ, Wang H, Shi Y. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 2010; 12: 154-165 [PMID: 20674860 DOI: 10.1016/j.cmet.2010.07.003]
41. Aoun M, Feillet-Coudray C, Fouret G, Chabi B, Crouzier D, Ferreri C, Chatgilialoglu C, Wrutniak-Cabello C, Cristol JP, Carbonneau MA, Coudray C. Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: effect of different nutritional lipid patterns. Br J Nutr 2012; 107: 647-659 [PMID: 21774841 DOI: 10.1017/S000711451100331X]
42. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192 [PMID: 11266382 DOI: 10.1053/gast.2001.23256]
43. Cortez-Pinto H, Zhi Lin H, Qi Yang S, Odwin Da Costa S, Diehl AM. Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 1999; 116: 1184-1193 [PMID: 10220511 DOI: 10.1016/s0016-5085(99)70022-3]
44. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO, Nisoli E. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 2006; 116: 2791-2798 [PMID: 16981010 DOI: 10.1172/jci28570]
45. Demeilliers C, Maisonneuve C, Grodet A, Mansouri A, Nguyen R, Tinel M, Lettéron P, Degott C, Feldmann G, Pessayre D, Fromenty B. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 2002; 123: 1278-1290 [PMID: 12360488 DOI: 10.1053/gast.2002.35952]
46. Santamaria E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, Corrales FJ. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci USA 2003; 100: 3065-3070 [PMID: 12631701 DOI: 10.1073/pnas.0536625100]
47. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40: 46-54 [PMID: 15239085]
48. García-Ruiz I, Rodríguez-Juan C, Díaz-Sanjuan T, del Hoyo P, Colina F, Muñoz-Yagüe T, Solís-Herruzo JA. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 2006; 44: 581-591 [PMID: 16941682]
49. Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A, Fernández-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158-1163 [PMID: 11732005]
50. Sánchez-Alcázar JA, Schneider E, Martínez MA, Carmona P, Hernández-Muñoz I, Siles E, De La Torre P, Ruiz-Cabello J, García I, Solis-Herruzo JA. Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 2000; 275: 13353-13361 [PMID: 10788444 DOI: 10.1074/jbc.275.18.13353]
51. Nagakawa Y, Williams GM, Zheng Q, Tsuchida A, Aoki T, Montgomery RA, Klein AS, Sun Z. Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha. Hepatology 2005; 42: 208-215 [PMID: 15962292 DOI: 10.1002/hep.20755]
52. Mittler R, Vanderauwera S, Suzuki N, Miller G, Tognetti VB, Vandepoele K, Gollery M, Shulaev V, Van Breusegem F. ROS signaling: the new wave? Trends Plant Sci 2011; 16: 300-309 [PMID: 21482172 DOI: 10.1016/j.tplants.2011.03.007]
53. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813-824 [PMID: 17848967 DOI: 10.1038/nrm2256]
54. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973; 134: 707-716 [PMID: 4749271]
55. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13 [PMID: 19061483 DOI: 10.1042/BJ20081386]
56. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 1985; 237: 408-414 [PMID: 2983613 DOI: 10.1016/0003-9861(85)90293-0]
57. Barja G. Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J Bioenerg Biomembr 1999; 31: 347-366 [PMID: 10665525]
58. Nohl H, Stolze K. Ubisemiquinones of the mitochondrial respiratory chain do not interact with molecular oxygen. Free Radic Res Commun 1992; 16: 409-419 [PMID: 1516850 DOI: 10.3109/10715769209049191]
59. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998; 27: 128-133 [PMID: 9425928 DOI: 10.1002/hep.510270121]
60. Schattenberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem 2005; 280: 9887-9894 [PMID: 15632182 DOI: 10.1074/jbc.m410310200]
61. Kono H, Rusyn I, Yin M, Gäbele E, Yamashina S, Dikalova A, Kadiiska MB, Connor HD, Mason RP, Segal BH, Bradford BU, Holland SM, Thurman RG. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000; 106: 867-872 [PMID: 11018074 DOI: 10.1172/jci9020]
62. Giulivi C, Poderoso JJ, Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 1998; 273: 11038-11043 [PMID: 9556586 DOI: 10.1074/jbc.273.18.11038]
63. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett 1997; 418: 291-296 [PMID: 9428730 DOI: 10.1016/s0014-5793(97)01397-5]
64. Venkatakrishnan P, Nakayasu ES, Almeida IC, Miller RT. Absence of nitric-oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem 2009; 284: 19843-19855 [PMID: 19372221 DOI: 10.1074/jbc.M109.003301]
65. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 1994; 356: 295-298 [PMID: 7805858 DOI: 10.1016/0014-5793(94)01290-3]
66. Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002; 33: 1451-1464 [PMID: 12446202 DOI: 10.1016/s0891-5849(02)01111-5]
67. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266: 4244-4250 [PMID: 1847917 DOI: 10.1016/0003-9861(91)90224-7]
68. Szabó C . DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 1996; 21: 855-869 [PMID: 8902531 DOI: 10.1016/0891-5849(96)00170-0]
69. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268: L699-L722 [PMID: 7762673]
70. Sarkela TM, Berthiaume J, Elfering S, Gybina AA, Giulivi C. The modulation of oxygen radical production by nitric oxide in mitochondria. J Biol Chem 2001; 276: 6945-6949 [PMID: 11106647 DOI: 10.1074/jbc.m007625200]
71. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345: 50-54 [PMID: 8194600 DOI: 10.1016/0014-5793(94)00424-2]
72. Bailey SM, Robinson G, Pinner A, Chamlee L, Ulasova E, Pompilius M, Page GP, Chhieng D, Jhala N, Landar A, Kharbanda KK, Ballinger S, Darley-Usmar V. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am J Physiol Gastrointest Liver Physiol 2006; 291: G857-G867 [PMID: 16825707 DOI: 10.1152/ajpgi.00044.2006]
73. Haynes V, Elfering S, Traaseth N, Giulivi C. Mitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulation. J Bioenerg Biomembr 2004; 36: 341-346 [PMID: 15377869 DOI: 10.1023/b:jobb.0000041765.27145.08]
74. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, Xu X, Murphy E, Darley-Usmar VM, Gladwin MT. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 2007; 100: 654-661 [PMID: 17293481 DOI: 10.1161/01.res.0000260171.52224.6b]
75. Gus'kova RA, Ivanov II, Kol'tover VK, Akhobadze VV, Rubin AB. Permeability of bilayer lipid membranes for superoxide (O2-.) radicals. Biochim Biophys Acta 1984; 778: 579-585 [PMID: 6095912]
76. Madesh M, Hajnóczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 2001; 155: 1003-1015 [PMID: 11739410 DOI: 10.1083/jcb.200105057]
77. García-Ruiz C, Morales A, Ballesta A, Rodés J, Kaplowitz N, Fernández-Checa JC. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994; 94: 193-201 [PMID: 8040260 DOI: 10.1172/jci117306]
78. Pastorino JG, Hoek JB. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 2000; 31: 1141-1152 [PMID: 10796891 DOI: 10.1053/he.2000.7013]
79. Yang S, Zhu H, Li Y, Lin H, Gabrielson K, Trush MA, Diehl AM. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000; 378: 259-268 [PMID: 10860543]
80. Armeni T, Pieri C, Marra M, Saccucci F, Principato G. Studies on the life prolonging effect of food restriction: glutathione levels and glyoxalase enzymes in rat liver. Mech Ageing Dev 1998; 101: 101-110 [PMID: 9593316 DOI: 10.1016/s0047-6374(97)00167-x]
81. Grattagliano I, Portincasa P, Cocco T, Moschetta A, Di Paola M, Palmieri VO, Palasciano G. Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats. Exp Gerontol 2004; 39: 1323-1332 [PMID: 15489055 DOI: 10.1016/j.exger.2004.06.001]
82. Llacuna L, Fernández A, Montfort CV, Matías N, Martínez L, Caballero F, Rimola A, Elena M, Morales A, Fernández-Checa JC, García-Ruiz C. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol 2011; 54: 1002-1010 [PMID: 21145825 DOI: 10.1016/j.jhep.2010.08.031]
83. Martínez-Chantar ML, García-Trevijano ER, Latasa MU, Pérez-Mato I, Sánchez del Pino MM, Corrales FJ, Avila MA, Mato JM. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr 2002; 76: 1177S-1182S [PMID: 12418501]
84. Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 2005; 42: 665-674 [PMID: 16116632 DOI: 10.1002/hep.20838]
85. Ricci C, Pastukh V, Leonard J, Turrens J, Wilson G, Schaffer D, Schaffer SW. Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol 2008; 294: C413-C422 [PMID: 18077603 DOI: 10.1152/ajpcell.00362.2007]
86. Nomoto K, Tsuneyama K, Takahashi H, Murai Y, Takano Y. Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease. Appl Immunohistochem Mol Morphol 2008; 16: 71-75 [PMID: 18091316 DOI: 10.1097/pai.0b013e31803156d5]
87. Sookoian S, Rosselli MS, Gemma C, Burgueño AL, Fernández Gianotti T, Castaño GO, Pirola CJ. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology 2010; 52: 1992-2000 [PMID: 20890895 DOI: 10.1002/hep.23927]
88. Haque A, Nishikawa M, Qian W, Mashimo M, Hirose M, Nishiguchi S, Inoue M. Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo. Hepatol Res 2006; 36: 209-216 [PMID: 16920399 DOI: 10.1016/j.hepres.2006.07.005]
89. Chiappini F, Barrier A, Saffroy R, Domart MC, Dagues N, Azoulay D, Sebagh M, Franc B, Chevalier S, Debuire B, Dudoit S, Lemoine A. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest 2006; 86: 154-165 [PMID: 16344856 DOI: 10.1038/labinvest.3700374]
90. Kawahara H, Fukura M, Tsuchishima M, Takase S. Mutation of mitochondrial DNA in livers from patients with alcoholic hepatitis and nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2007; 31: S54-S60 [PMID: 17331167 DOI: 10.1111/j.1530-0277.2006.00287.x]
91. Van Remmen H, Hamilton ML, Richardson A. Oxidative damage to DNA and aging. Exerc Sport Sci Rev 2003; 31: 149-153 [PMID: 12882482]
92. Musatov A, Carroll CA, Liu YC, Henderson GI, Weintraub ST, Robinson NC. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 2002; 41: 8212-8220 [PMID: 12069614 DOI: 10.1021/bi025896u]
93. Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 2004; 16: 1095-1105 [PMID: 15489566]
94. Chen J, Petersen DR, Schenker S, Henderson GI. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase. Alcohol Clin Exp Res 2000; 24: 544-552 [PMID: 10798592 DOI: 10.1111/j.1530-0277.2000.tb02023.x]
95. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RC, Wiswedel I, Zarkovic K, Zarkovic N. Pathological aspects of lipid peroxidation. Free Radic Res 2010; 44: 1125-1171 [PMID: 20836660 DOI: 10.3109/10715762.2010.498478]
96. Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium 2009; 45: 643-650 [PMID: 19368971 DOI: 10.1016/j.ceca.2009.03.012]
97. Musatov A, Robinson NC. Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase. Free Radic Res 2012; 46: 1313-1326 [PMID: 22856385 DOI: 10.3109/10715762.2012.717273]
98. Schlame M, Ren M. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim Biophys Acta 2009; 1788: 2080-2083 [PMID: 19413994 DOI: 10.1016/j.bbamem.2009.04.019]
99. Acín-Pérez R, Fernández-Silva P, Peleato ML, Pérez-Martos A, Enriquez JA. Respiratory active mitochondrial supercomplexes. Mol Cell 2008; 32: 529-539 [PMID: 19026783 DOI: 10.1016/j.molcel.2008.10.021]
100. Zhang M, Mileykovskaya E, Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem 2005; 280: 29403-29408 [PMID: 15972817 DOI: 10.1074/jbc.m504955200]
101. Claypool SM, Koehler CM. The complexity of cardiolipin in health and disease. Trends Biochem Sci 2012; 37: 32-41 [PMID: 22014644 DOI: 10.1016/j.tibs.2011.09.00]
102. Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin. Neurochem Int 2011; 58: 447-457 [PMID: 21215780 DOI: 10.1016/j.neuint.2010.12.016]
103. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 2000; 466: 323-326 [PMID: 10682852 DOI: 10.1016/s0014-5793(00)01082-6]
104. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles. Mitochondrion 2001; 1: 151-159 [PMID: 16120275 DOI: 10.1016/s1567-7249(01)00011-3]
105. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 2002; 286: 135-141 [PMID: 11943469 DOI: 10.1016/s0378-1119(01)00814-9]
106. Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol 2012; 28: 159-165 [PMID: 22134222 DOI: 10.1097/MOG.0b013e32834e7b4b]
107. Sharpley MS, Shannon RJ, Draghi F, Hirst J. Interactions between phospholipids and NADH: ubiquinone oxidoreductase (complex I) from bovine mitochondria. Biochemistry 2006; 45: 241-248 [PMID: 16388600 DOI: 10.1021/bi051809x]
108. Schönfeld P, Wojtczak L. Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta 2007; 1767: 1032-1040 [PMID: 17588527 DOI: 10.1016/j.bbabio.2007.04.005]
109. Srivastava S, Chan C. Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: relation to mitochondrial permeability transition. Free Radic Res 2007; 41: 38-49 [PMID: 17164177 DOI: 10.1080/10715760600943900]
110. Maranzana E, Barbero G, Falasca AI, Lenaz G, Genova ML. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid Redox Signal 2013; 19: 1469-1480 [PMID: 23581604 DOI: 10.1089/ars.2012.4845]
111. McKenzie M, Lazarou M, Thorburn DR, Ryan MT. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients. J Mol Biol 2006; 361: 462-469 [PMID: 16857210 DOI: 10.1016/j.jmb.2006.06.057]
112. Ferreira R, Guerra G, Padrão AI, Melo T, Vitorino R, Duarte JA, Remião F, Domingues P, Amado F, Domingues MR. Lipidomic characterization of streptozotocin-induced heart mitochondrial dysfunction. Mitochondrion 2013; 13: 762-771 [PMID: 23665486 DOI: 10.1016/j.mito.2013.05.001]
113. Yuan J, Horvitz HR. A first insight into the molecular mechanisms of apoptosis. Cell 2004; 116: S53-S56, 1 p following S59 [PMID: 15055582 DOI: 10.1016/s0092-8674(04)00028-5]
114. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907 [PMID: 15520809 DOI: 10.1038/nrm1496]
115. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647-656 [PMID: 12209154 DOI: 10.1038/nrc883]
116. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-490 [PMID: 9727491 DOI: 10.1016/s0092-8674(00)81589-5]
117. Petrosillo G, Casanova G, Matera M, Ruggiero FM, Paradies G. Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: induction of permeability transition and cytochrome c release. FEBS Lett 2006; 580: 6311-6316 [PMID: 17083938 DOI: 10.1016/j.febslet.2006.10.036]
118. Crompton M . The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341 (Pt 2): 233-249 [PMID: 10393078 DOI: 10.1042/0264-6021:3410233]
119. Leung AW, Halestrap AP. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 2008; 1777: 946-952 [PMID: 18407825 DOI: 10.1016/j.bbabio.2008.03.009]
120. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 2009; 46: 821-831 [PMID: 19265700 DOI: 10.1016/j.yjmcc.2009.02.021]
121. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, Glick GD, Petronilli V, Zoratti M, Szabó I, Lippe G, Bernardi P. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 2013; 110: 5887-5892 [PMID: 23530243 DOI: 10.1073/pnas.1217823110]
122. Petrosillo G, Moro N, Ruggiero FM, Paradies G. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med 2009; 47: 969-974 [PMID: 19577639 DOI: 10.1016/j.freeradbiomed.2009.06.032]
123. Teodoro JS, Rolo AP, Duarte FV, Simões AM, Palmeira CM. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion 2008; 8: 367-376 [PMID: 18765303 DOI: 10.1016/j.mito.2008.07.008]
124. Rytömaa M, Mustonen P, Kinnunen PK. Reversible, nonionic, and pH-dependent association of cytochrome c with cardiolipin-phosphatidylcholine liposomes. J Biol Chem 1992; 267: 22243-22248 [PMID: 1331048 DOI: 10.1021/bi952413w]
125. Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, Kini V, Amoscato AA, Fujii Y. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med 2004; 37: 1963-1985 [PMID: 15544916 DOI: 10.1016/j.freeradbiomed.2004.08.016]
126. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437-443 [PMID: 12891546]
127. Tome S, Lucey MR. Review article: current management of alcoholic liver disease. Aliment Pharmacol Ther 2004; 19: 707-714 [PMID: 15043511 DOI: 10.1111/j.1365-2036.2004.01881.x]
128. Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007; 18: 184-195 [PMID: 17296492 DOI: 10.1016/j.jnutbio.2006.12.006]
129. Comar KM, Sterling RK. Review article: Drug therapy for nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2006; 23: 207-215 [PMID: 16393299 DOI: 10.1111/j.1365-2036.2006.02751.x]
130. Federico A, Trappoliere M, Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Dig Liver Dis 2006; 38: 789-801 [PMID: 16750661 DOI: 10.1016/j.dld.2006.04.009]
131. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem 2006; 13: 2889-2900 [PMID: 17073635 DOI: 10.2174/092986706778521878]
132. Serviddio G, Bellanti F, Sastre J, Vendemiale G, Altomare E. Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem 2010; 17: 2325-2337 [PMID: 20491641 DOI: 10.2174/092986710791698530]
133. Pi J, Zhang Q, Fu J, Woods CG, Hou Y, Corkey BE, Collins S, Andersen ME. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol 2010; 244: 77-83 [PMID: 19501608 DOI: 10.1016/j.taap.2009.05.025]
134. Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007; 47: 629-656 [PMID: 17014364 DOI: 10.1146/annurev.pharmtox.47.120505.105110]
135. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005; 19: 1088-1095 [PMID: 15985532 DOI: 10.1096/fj.05-3718com]
136. Skulachev VP, Antonenko YN, Cherepanov DA, Chernyak BV, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Pletjushkina OY, Roginsky VA, Rokitskaya TI, Severin FF, Severina II, Simonyan RA, Skulachev MV, Sumbatyan NV, Sukhanova EI, Tashlitsky VN, Trendeleva TA, Vyssokikh MY, Zvyagilskaya RA. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta 2010; 1797: 878-889 [PMID: 20307489 DOI: 10.1016/j.bbabio.2010.03.015]]
137. Reily C, Mitchell T, Chacko BK, Benavides G, Murphy MP, Darley-Usmar V. Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol 2013; 1: 86-93 [PMID: 23667828]
138. Acuña Castroviejo D, Escames G, Carazo A, León J, Khaldy H, Reiter RJ. Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem 2002; 2: 133-151 [PMID: 11899097 DOI: 10.2174/1568026023394344]
139. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310 [PMID: 20433638 DOI: 10.1111/j.1600-079X.2010.00759.x]
140. Peng TI, Hsiao CW, Reiter RJ, Tanaka M, Lai YK, Jou MJ. mtDNA T8993G mutation-induced mitochondrial complex V inhibition augments cardiolipin-dependent alterations in mitochondrial dynamics during oxidative, Ca(2+), and lipid insults in NARP cybrids: a potential therapeutic target for melatonin. J Pineal Res 2012; 52: 93-106 [PMID: 21812817 DOI: 10.1111/j.1600-079X.2011.00923.x]
141. Petrosillo G, Colantuono G, Moro N, Ruggiero FM, Tiravanti E, Di Venosa N, Fiore T, Paradies G. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009; 297: H1487-H1493 [PMID: 19684190 DOI: 10.1152/ajpheart.00163.2009]
142. Petrosillo G, De Benedictis V, Ruggiero FM, Paradies G. Decline in cytochrome c oxidase activity in rat-brain mitochondria with aging. Role of peroxidized cardiolipin and beneficial effect of melatonin. J Bioenerg Biomembr 2013; 45: 431-440 [PMID: 23494666 DOI: 10.1007/s10863-013-9505-0]
143. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 2014; 171: 2029-2050 [PMID: 24117165 DOI: 10.1111/bph.12461]